Tower Research Capital LLC (Trc) Biogen Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Biogen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,956 shares of BIIB stock, worth $887,563. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,956

Previous 15,468 61.49%

Holding current value

$887,563

Previous $3.59 Million 67.81%

% of portfolio

0.03%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $1.8 Million - $2.25 Million	-9,512 Reduced 61.49%	5,956 $1.15 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $773,892 - $961,556	4,062 Added 35.61%	15,468 $3.59 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $3.39 Million - $4.28 Million	-15,983 Reduced 58.36%	11,406 $2.46 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $3.85 Million - $4.64 Million	17,302 Added 171.53%	27,389 $7.09 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.66 Million - $1.88 Million	6,561 Added 186.07%	10,087 $2.59 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $77,620 - $89,692	282 Added 8.69%	3,526 $1 Million
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $452,571 - $515,687	-1,764 Reduced 35.22%	3,244 $901,000
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $7.77 Million - $9.44 Million	-30,785 Reduced 86.01%	5,008 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $778,954 - $1.07 Million	4,001 Added 12.58%	35,793 $9.56 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $2.87 Million - $3.41 Million	-15,292 Reduced 32.48%	31,792 $6.48 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $6.65 Million - $8.38 Million	34,339 Added 269.43%	47,084 $9.92 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $390,740 - $502,158	1,745 Added 15.86%	12,745 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.21 Million - $1.57 Million	4,263 Added 63.28%	11,000 $3.11 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.41 Million - $5.46 Million	-13,174 Reduced 66.16%	6,737 $2.33 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.17 Million - $3.72 Million	13,068 Added 190.97%	19,911 $5.57 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $144,591 - $217,645	-612 Reduced 8.21%	6,843 $1.68 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $749,563 - $865,465	2,831 Added 61.22%	7,455 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $1.18 Million - $1.56 Million	4,552 Added 6322.22%	4,624 $1.24 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $28,766 - $36,491	-107 Reduced 59.78%	72 $23,000
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $466,967 - $645,236	-2,122 Reduced 92.22%	179 $53,000
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $1.06 Million - $1.18 Million	-4,856 Reduced 67.85%	2,301 $536,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $614,669 - $677,541	2,803 Added 64.38%	7,157 $1.67 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $817,646 - $1.28 Million	3,773 Added 649.4%	4,354 $1.03 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.87 Million - $2.37 Million	-6,732 Reduced 92.06%	581 $175,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $2.14 Million - $2.8 Million	-7,303 Reduced 49.97%	7,313 $2.58 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $3.47 Million - $4.13 Million	13,459 Added 1163.27%	14,616 $4.24 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $24,972 - $35,319	-96 Reduced 7.66%	1,157 $317,000
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $119,364 - $133,697	-388 Reduced 23.64%	1,253 $399,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $461,367 - $541,021	1,641	1,641 $513,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Biogen Inc. Transaction History